These include: Nausea (the most common complaint, particularly in the first few weeks) Vomiting Diarrhoea or constipation Decreased appetite (which, while therapeutically desirable, can occasionally be excessive) Abdominal discomfort or bloating Injection-site reactions (such as redness, itching, or mild swelling at the injection site) Headache, dizziness, and fatigue , particularly during early treatment These effects are generally dose-dependent and tend to diminish as the body adjusts to the medication
The question is: which conditions count
Answer: CJC-1295 and Ipamorelin are typically given as small subcutaneous injections prescribed and supervised by a clinician, with the schedule set to align with the body's natural overnight growth hormone release
A lot of those cases are related to people trying to use (the drug) therapeutically and making a mistake with administering the medication, said Kait Brown, clinical managing director of Americas Poison Centers
- Collagen Production: Supports skin health and wound healing
Journal of Ethnopharmacology 194